Results from a randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy (REASON).

C. Lhommé, Mario Campone, Florence Joly et al.|Journal of Clinical Oncology|2011

Cited by 3